From our results, BCAT1 is higher expressed in glioblastoma than in lower grade gliomas and higher in astrocytoma than in oligodendroglioma as well as higher in classical and mesenchymal subtypes than in proneural subtype glioblastoma. Here, BCAT1 is linked to central nervous system cancer.